Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 27, 2023, Peter Thompson, M.D., a director of Janux Therapeutics, Inc. (the "Company"), informed the Company that he does not intend to stand for re-election as a member of the Board of Directors at the Company's 2023 annual meeting of stockholders as a result of competing commitments. Dr. Thompson's decision to not stand for re-election is not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.


                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses